JPX:4570
Immuno-Biological Laboratories Co., Ltd. · JPX · Healthcare · JPY · FY for 2026
Figures on this page computed 2026-11-07 14:24 UTC
Last close
n/aJPY
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
25.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
32.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
26.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Price is the furthest below its sector's middle: 0.24 against 0.37 on the market's range.
- Growth10.8%61 of 100, above its sector
- Returns on capital17.9%89 of 100, above its sector
- Margins69.7%91 of 100, above its sector
- Price25.9x24 of 100, below its sector
- Safety5.6892 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.30x
Its own average over 7 years, 773.2M.
- Profit-2.99x
Its own average over 7 years, -110.1M.
- Free cash flow-4.99x
Its own average over 7 years, -53.7M.
- Debt0.84x
Its own average over 7 years, 211.8M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at -4.99 times.
The filed years, as a table
7Each line is 100 at 2020-03-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2020-03-31 | 100.0 | 100.0 |
| 2021-03-31 | 104.6 | 106.0 |
| 2022-03-31 | 112.4 | 106.0 |
| 2023-03-31 | 138.0 | 106.0 |
| 2024-03-31 | 141.8 | 106.0 |
| 2025-03-31 | 168.3 | 106.0 |
| 2026-03-31 | 174.5 | 106.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
Figures behind the shape
Growth
10.8%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate10.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
One-year change in net income32.1%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Returns on capital
17.9%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity17.9%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets15.3%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
69.7%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin69.7%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin28.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin32.7%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin26.6%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
25.9xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings25.9x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
Price to book4.6x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio8.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
5.68safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio5.68
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage211.0x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score18.51
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.